Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kontafarma China Holdings Ltd ( (HK:1312) ) has provided an announcement.
Kontafarma China Holdings Ltd held its Annual General Meeting on June 24, 2025, where all proposed resolutions were passed unanimously by shareholders. These resolutions included the adoption of financial statements, re-election of directors, authorization of directors’ fees, re-appointment of auditors, and granting of mandates for securities issuance and share buybacks. The successful passing of these resolutions reflects strong shareholder support and positions the company for continued operational stability and strategic growth.
More about Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd is a company incorporated in the Cayman Islands, focusing on various business sectors in China. The company is involved in the production and distribution of health and wellness products, pharmaceuticals, and other related services, catering to the growing demand in the Chinese market.
Average Trading Volume: 1,005,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$156.2M
For detailed information about 1312 stock, go to TipRanks’ Stock Analysis page.